首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
【2h】

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

机译:14种抗生素的体外活性针对南部非洲鼠疫疫情的100株鼠疫耶尔森菌分离株。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A limited repertoire of antimicrobial agents is currently in use for the treatment of plague. We investigated the in vitro activities of some newer antimicrobial agents against Yersinia pestis. Among the injectable agents tested, cefotaxime was the most active, and among the oral agents, both levofloxacin and ofloxacin were highly active, with MICs at which 90% of isolates are inhibited of < 0.03 microgram/ml. the susceptibilities to the ketolide RU004 and the penem faropenem warrant attention. The enhanced activities of quinolones against Y. pestis suggest that these agents should be further investigated for the treatment of human plague in the future.
机译:目前使用有限的抗菌剂库来治疗鼠疫。我们调查了一些抗鼠疫耶尔森氏菌的新型抗菌药物的体外活性。在所测试的注射剂中,头孢噻肟是最有效的,而在口服剂中,左氧氟沙星和氧氟沙星都具有很高的活性,MIC抑制了90%的分离物<0.03微克/毫升。对酮内酯RU004和青霉菌法罗培南的敏感性值得关注。喹诺酮类药物对鼠疫耶尔森氏菌的活性增强表明,将来应进一步研究这些药物以治疗人类瘟疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号